Actively Recruiting
Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
Led by University Hospital, Toulouse · Updated on 2024-10-30
80
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The understanding of ARVC pathophysiology remains incomplete. Several clues indicate that disease progression is mediated through inflammation. The present study aim to document the feasibility of detecting the potential presence of intracardiac local inflammatory components in patients with ARVC.
CONDITIONS
Official Title
Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of arrhythmogenic right ventricular dysplasia according to 2010 Task Force Criteria
- Admission for right ventricle electrophysiologic mapping
- Admission for ablation procedures (accessory pathway, atrial flutter) on otherwise healthy hearts
You will not qualify if you...
- Diagnosis of systemic chronic inflammatory disease
- Presence of any possible or confirmed cardiac involvement from inflammatory disease or infectious disease (acute or chronic)
- Use of immunosuppressant or immunomodulating medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Toulouse University Hospital Center
Toulouse, France
Actively Recruiting
Research Team
P
Philippe MAURY, MD
CONTACT
M
Maxime BENEYTO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here